The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity.
Colin B PageNicole M RyanGeoffrey K IsbisterPublished in: Clinical toxicology (Philadelphia, Pa.) (2017)
Despite the benefits of HIE in toxin-induced cardiac toxicity, it caused significant disruption to glucose and electrolyte homeostasis, although there were no apparent complications from this. There was no association by comparing the amount of insulin administered on adverse effects or glucose administered, suggesting higher doses of insulin are associated with no more adverse effects.
Keyphrases
- type diabetes
- high dose
- escherichia coli
- high glucose
- diabetic rats
- glycemic control
- oxidative stress
- left ventricular
- blood glucose
- drug induced
- low dose
- risk factors
- magnetic resonance
- computed tomography
- magnetic resonance imaging
- heart failure
- skeletal muscle
- atrial fibrillation
- adipose tissue
- mesenchymal stem cells
- cell therapy
- smoking cessation
- oxide nanoparticles
- ion batteries